Concentriq is Designed for Research and Clinical Workflows.
Concentriq, our AI-powered software platform sits at the intersection of digital and computational pathology, where functionality needed to carry out routine pathology operations connects with powerful AI applications to accelerate breakthroughs and improve patient outcomes.
Powering primary diagnostic workflows to drive efficiency and improve quality.
Centralizing and unifying data-centric research from discovery to market.
AI-powered pathology for the modern laboratory
Concentriq delivers access to the broadest portfolio of computational applications, fully integrated into routine workflows.
PRESS RELEASE: Unilabs selects Proscia to advance its aspiration of becoming the most digitally driven diagnostic group.
Streamline the journey
from discovery to market.
Modern pathology software helps solve R&D’s biggest challenges. Improve data integrity and quality, run more studies and experiments faster and uncover new insights.
Webinar: New in Concentriq for Research 3.9: Expanded Capabilities for Preclinical R&D
Join our upcoming webinar on May 3, 2023 at 11:00AM ET and learn about important enhancements we’ve made to Concentriq for Research to help you and your team accelerate GLP and non-regulated drug safety studies.
Run a modern,
more productive lab.
Accelerate your shift to 100% digital diagnosis to improve diagnostic quality, increase efficiency and position your lab for future growth.
Panel Discussion: The Use of AI in Routine,
High-Throughput Workflows
Hear real-world experiences from pathologists at LabPON and Unilabs, along with partners Ibex Medical Analytics and Visiopharm.
We believe that pathology deserves great technology.
We’re helping labs and research centers take advantage of the collaboration, insight, accuracy and time-saving benefits of digital pathology, and accelerating breakthroughs in the fight against cancer. Learn more about our vision for powering this new era of data-driven pathology.
Latest News
Press Release
Agilent Announces Global Distribution Agreement with Proscia to Accelerate Data-Driven Precision Medicine
Press Release
PathGroup Chooses Proscia To Deliver Next Generation Of Cancer Diagnosis For Millions of Patients